Excitement grows around Eli Lilly's GLP-1 drugs in Q2 earnings

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 48 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 40%
  • Publisher: 63%

Eli Lilly Nouvelles

Jared Holz,Pharmaceutical Giant,Weight-Loss Drugs

Shares of Eli Lilly (LLY) are jumping after the company posted second quarter earnings results, beating expectations on both the top and bottom lines. The...

on both the top and bottom lines. The pharmaceutical giant raised its revenue outlook based on surging demand for its weight-loss drugs, Mounjaro and Zepbound.

S the company blue past analysts expectations in its second quarter, also raised its full year revenue outlook here for a deeper dive into these results.He is mzs Health Care Equity strategist, Jared lots to talk about here within this report, but at least on the surface or really what's driving the action is a lot of the excitement surrounding the weight loss drugs.Of course, one of the questions going into this print was the ability to meet demand.

So as soon as capacity kind of starts rolling here, I think you're gonna see a lot of upside to numbers for the next few years. You know, some of the compounders have been able to find success here early on because of the supply issues at Novo and Lily. So I think for most patients, they want the branded product, the inability to get it has been the gating factor.

“Saturday Night” Trailer Rewinds to 1975 for Uncanny Look at “SNL”'s Chevy Chase, John Belushi and More

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 47. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Eli Lilly stock surges on Q2 earnings beat, revenue outlookShares of Eli Lilly (LLY) are jumping in early trading. The drugmaker reported second quarter results that handily beat Street estimates. The company also...
La source: YahooFinanceCA - 🏆 47. / 63 Lire la suite »